MEDARTIS NMEDARTIS NMEDARTIS N

MEDARTIS N

No trades
See on Supercharts
Market capitalization
‪706.97 M‬CHF
‪619.00 K‬CHF
‪212.01 M‬CHF
‪12.96 M‬
Beta (1Y)
0.87
Employees (FY)
876
Revenue / Employee (1Y)
‪287.45 K‬CHF
Net income / Employee (1Y)
839.28CHF

About MEDARTIS N


CEO
Matthias Schupp
Headquarters
Basel
Founded
1997
ISIN
CH0386200239
FIGI
BBG00K68NZ53
Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. It operates through the following geographical segments: EMEA, US, APAC, and LATAM. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MED is 52.2 CHF — it has increased by 0.38% in the past 24 hours. Watch MEDARTIS N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange MEDARTIS N stocks are traded under the ticker MED.
MED stock has fallen by −5.61% compared to the previous week, the month change is a −5.26% fall, over the last year MEDARTIS N has showed a −29.84% decrease.
We've gathered analysts' opinions on MEDARTIS N future price: according to them, MED price has a max estimate of 110.00 CHF and a min estimate of 85.00 CHF. Watch MED chart and read a more detailed MEDARTIS N stock forecast: see what analysts think of MEDARTIS N and suggest that you do with its stocks.
MED reached its all-time high on Mar 10, 2022 with the price of 148.4 CHF, and its all-time low was 0.5 CHF and was reached on Dec 16, 2002. View more price dynamics on MED chart.
See other stocks reaching their highest and lowest prices.
MED stock is 5.56% volatile and has beta coefficient of 0.87. Track MEDARTIS N stock price on the chart and check out the list of the most volatile stocks — is MEDARTIS N there?
Today MEDARTIS N has the market capitalization of ‪709.68 M‬, it has decreased by −1.55% over the last week.
Yes, you can track MEDARTIS N financials in yearly and quarterly reports right on TradingView.
MEDARTIS N revenue for the last half-year amounts to ‪111.50 M‬ CHF, despite the estimated figure of ‪114.25 M‬ CHF. In the next half-year revenue is expected to reach ‪120.95 M‬ CHF.
MED net income for the last half-year is ‪2.56 M‬ CHF, while the previous report showed ‪1.47 M‬ CHF of net income which accounts for 74.84% change. Track more MEDARTIS N financial stats to get the full picture.
No, MED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 876.00 employees. See our rating of the largest employees — is MEDARTIS N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDARTIS N EBITDA is ‪25.93 M‬ CHF, and current EBITDA margin is 15.30%. See more stats in MEDARTIS N financial statements.
Like other stocks, MED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDARTIS N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDARTIS N technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDARTIS N stock shows the sell signal. See more of MEDARTIS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.